{"id":"carbifene","rwe":[],"tags":[{"label":"carbifene","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"etomide","offLabel":[],"synonyms":["carbiphene","carbifene","etomide","etymide","carbiphene hydrochloride","carbiphene HCl"],"timeline":[],"brandName":"Etomide","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"carbifene","explanation":"Imagine your body's cells are like locks, and proteins are like keys. Etomide is a key that fits into a specific lock, changing the way the lock works and allowing the cell to function differently. This can help to treat certain diseases or conditions, but it can also have unintended effects if the lock is not the right one.","oneSentence":"Etomide works by binding to a specific protein or receptor, altering its function and leading to a therapeutic effect.","technicalDetail":"Etomide is a small molecule that likely acts as a competitive antagonist or agonist at its target receptor, modulating its activity and leading to a therapeutic response."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3700","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=carbifene","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:10:13.951651","biosimilars":[],"competitors":[],"genericName":"carbifene","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"NJQ5FL8Q43","CHEBI":"CHEBI:135698","INN_ID":"2080","UMLSCUI":"C2698990","ChEMBL_ID":"CHEMBL2110882","KEGG_DRUG":"D03389","PUBCHEM_CID":"10080","SECONDARY_CAS_RN":"467-22-1"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Etomide, also known as carbifene, is a small molecule drug of unknown target and class. Its commercial status and approved indications are currently unknown. As a small molecule, it is likely to work by binding to a specific protein or receptor, but the exact mechanism is not well-documented. Further research is needed to fully understand its effects and potential side effects. Its development and approval status are also unclear.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}